# Phio Pharmaceuticals Corp. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:25690616-6571-471a-9292-5baa843e70ef | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/phio-pharmaceuticals-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-14T04:47:14.667721+00:00 | | Last reviewed | 2026-10-14T04:47:14.667721+00:00 | ## Identity - Legal name: Phio Pharmaceuticals Corp. - Display name: Phio Pharmaceuticals Corp. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-14T06:20:52.729446+00:00 | | Completeness | 0.409 | | Record Quality | 0.837 | | Directors | 5 | | Committees | 4 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Curtis A. Lockshin, Ph.D.: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:5 - David H. Deming: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:6 - Jonathan E. Freeman, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:7 - Patricia A. Bradford: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8 - Robert L. Ferrara: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9 ## Committees - Audit (audit). Chair: Robert L. Ferrara. Members: Robert L. Ferrara (chair, current); Patricia A. Bradford (member, current). committee_id=alpha:committee:phio-pharmaceuticals-corp:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Robert L. Ferrara (member, current). committee_id=alpha:committee:phio-pharmaceuticals-corp:audit-chair-compensation - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Patricia A. Bradford (member, current). committee_id=alpha:committee:phio-pharmaceuticals-corp:audit-compensation-chair - Compensation (compensation). Chair: Patricia A. Bradford. Members: Patricia A. Bradford (chair, current); Robert L. Ferrara (member, current). committee_id=alpha:committee:phio-pharmaceuticals-corp:compensation ## Executive leadership - Lisa C. Carson: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:10 - Robert J. Bitterman: President, Chief Executive Officer and Chair of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:11 - Robert M. Infarinato: Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:12 ## Governance events - CFO_CHANGED: Lisa C. Carson executive of Phio Pharmaceuticals Corp., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:aw0arm1vefzse - CEO_CHANGED: Robert J. Bitterman executive of Phio Pharmaceuticals Corp., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1t2qjtf1fcs5n3 - CFO_CHANGED: Robert M. Infarinato executive of Phio Pharmaceuticals Corp., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1tpmhbow1ee3i - DIRECTOR_APPOINTED: David H. Deming seat on Phio Pharmaceuticals Corp., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:oieeu613l9hp0 - DIRECTOR_APPOINTED: Patricia A. Bradford seat on Phio Pharmaceuticals Corp., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1ho680h13akvqx - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Phio Pharmaceuticals Corp., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1opxnu513s0pi1 - COMMITTEE_MEMBER_ADDED: Patricia A. Bradford member of Audit; Compensation · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1ws93fx111mgc7 - DIRECTOR_APPOINTED: Robert L. Ferrara seat on Phio Pharmaceuticals Corp., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:7q670q14sq0us - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Phio Pharmaceuticals Corp., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1yxmqje17ris44 - COMMITTEE_MEMBER_ADDED: Robert L. Ferrara member of Audit · Chair; Compensation, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:gb047o6efx72 - DIRECTOR_APPOINTED: Jonathan E. Freeman, Ph.D. seat on Phio Pharmaceuticals Corp., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1xe4bx827mnnc - DIRECTOR_APPOINTED: Curtis A. Lockshin, Ph.D. seat on Phio Pharmaceuticals Corp., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-14T04:47:14.667721+00:00. event_id=alpha:event:transition:1r8k4ys1cf84wq ## Scoped resources - `alpha://company/phio-pharmaceuticals-corp` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record - `alpha://company/phio-pharmaceuticals-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=identity - `alpha://company/phio-pharmaceuticals-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=corporate-structure - `alpha://company/phio-pharmaceuticals-corp/board` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=board - `alpha://company/phio-pharmaceuticals-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=committees - `alpha://company/phio-pharmaceuticals-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=leadership - `alpha://company/phio-pharmaceuticals-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=ownership - `alpha://company/phio-pharmaceuticals-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=financials - `alpha://company/phio-pharmaceuticals-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=capital-structure - `alpha://company/phio-pharmaceuticals-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=compensation - `alpha://company/phio-pharmaceuticals-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=governance - `alpha://company/phio-pharmaceuticals-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=shareholder-governance - `alpha://company/phio-pharmaceuticals-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=audit - `alpha://company/phio-pharmaceuticals-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=legal - `alpha://company/phio-pharmaceuticals-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=risk - `alpha://company/phio-pharmaceuticals-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=cyber - `alpha://company/phio-pharmaceuticals-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=ai-governance - `alpha://company/phio-pharmaceuticals-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=agents - `alpha://company/phio-pharmaceuticals-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=ecosystem - `alpha://company/phio-pharmaceuticals-corp/events` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=events - `alpha://company/phio-pharmaceuticals-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=relationships - `alpha://company/phio-pharmaceuticals-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=assessments - `alpha://company/phio-pharmaceuticals-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:robert-l-ferrara","name":"Robert L. Ferrara"},"source_id":"board_seats"}` - Claim alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:patricia-a-bradford","name":"Patricia A. Bradford"},"source_id":"board_seats"}` - Claim alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:patricia-a-bradford","name":"Patricia A. Bradford"},"source_id":"board_seats"}` - Claim alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:robert-l-ferrara","name":"Robert L. Ferrara"},"source_id":"board_seats"}` ## Leadership - Curtis A. Lockshin, Ph.D.: Director. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:5. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824. - David H. Deming: Director. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824. - Jonathan E. Freeman, Ph.D.: Director. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:7. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824. - Patricia A. Bradford: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824. - Robert L. Ferrara: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824. - Lisa C. Carson: Chief Financial Officer. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:10. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3b05fad10b6f6a3d5fb0c8a582be2f47fcbeac8f513e471cb9ef64fb95e56952. - Robert J. Bitterman: President, Chief Executive Officer and Chair of the Board of Directors. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:11. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aae71f8700e0e950e751b612ad278fd0e7f8848c800a0409795219c04daf893b. - Robert M. Infarinato: Vice President and Chief Financial Officer. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:12. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:89dd0d65aeca683bb65523e7cb0c86aa0776c94c8b51dd4410b8e5d0d34e79eb. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Robert L. Ferrara; Members Robert L. Ferrara (Chair); Patricia A. Bradford. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. - Compensation: Chair Patricia A. Bradford; Members Patricia A. Bradford (Chair); Robert L. Ferrara. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Phio Pharmaceuticals Corp.. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7a5c5999889ccf9291f19dcdf5c4076f8c38c1a3dd978d5904da260fe751e43c. ## Entity Status - Public listing published. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7a5c5999889ccf9291f19dcdf5c4076f8c38c1a3dd978d5904da260fe751e43c. ## Published Fact - US. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7a5c5999889ccf9291f19dcdf5c4076f8c38c1a3dd978d5904da260fe751e43c. ## Committee Appointment - Robert L. Ferrara: chair, Audit. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. - Patricia A. Bradford: member, Audit. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. - Patricia A. Bradford: chair, Compensation. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. - Robert L. Ferrara: member, Compensation. Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d. ## Security Listing - PHIO (NASDAQ). Claim: alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7a5c5999889ccf9291f19dcdf5c4076f8c38c1a3dd978d5904da260fe751e43c. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:7a5c5999889ccf9291f19dcdf5c4076f8c38c1a3dd978d5904da260fe751e43c: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/phio-pharmaceuticals-corp). - alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824: [Phio Pharmaceuticals Corp. DEF 14A 2025-07-30](https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm). - alpha:projection-evidence:document:3b05fad10b6f6a3d5fb0c8a582be2f47fcbeac8f513e471cb9ef64fb95e56952: [PHIO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm). - alpha:projection-evidence:document:aae71f8700e0e950e751b612ad278fd0e7f8848c800a0409795219c04daf893b: [PHIO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm). - alpha:projection-evidence:document:89dd0d65aeca683bb65523e7cb0c86aa0776c94c8b51dd4410b8e5d0d34e79eb: [PHIO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm). - alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d: [Audit](https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/phio-pharmaceuticals-corp) - [Public Markdown](https://registry.alpha.ac/companies/phio-pharmaceuticals-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=jsonld) - MCP resource: `alpha://companies/phio-pharmaceuticals-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-14T06:20:52.516061+00:00; recorded 2026-10-14T06:20:52.516061+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.